A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma

Study acronym: Clarity-BR
StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a retrospective observational registry study designed to characterise patient profiles, assess treatment patterns, evaluate clinical outcomes and explore COO testing patterns among adult patients with newly diagnosed LDGCB who have not previously received treatment (TN) and are receiving first-line (1L) treatment.
Trial Details
NCT Number NCT07882576
Lead Sponsor AstraZeneca
Conditions
(from sponsor)		 Lymphoma, B-Cell
Related terms Lymphoma, Lymphoma, B-Cell
Enrollment 532 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov